BIOMAT Database Logo BIOMAT Database Logo

Antitoxin treatment for botulism. 1968

M G Koenig, and D E Rogers

UI MeSH Term Description Entries
D001906 Botulism A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208) Botulism, Infantile,Botulism, Toxico-Infectious,Clostridium botulinum Infection,Foodborne Botulism,Infant Botulism,Toxico-Infectious Botulism,Wound Botulism,Botulism, Foodborne,Botulism, Infant,Botulism, Toxico Infectious,Botulism, Wound,Clostridium botulinum Infections,Foodborne Botulisms,Infant Botulisms,Infantile Botulism,Infection, Clostridium botulinum,Toxico Infectious Botulism,Wound Botulisms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000992 Antitoxins Antisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS. Antitoxin

Related Publications

M G Koenig, and D E Rogers
Antitoxin treatment for botulism.
July 1968, The New England journal of medicine,
M G Koenig, and D E Rogers
[Botulism antitoxin treatment in two cases of foodborne botulism].
January 2010, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria,
M G Koenig, and D E Rogers
Equine botulinum antitoxin for the treatment of infant botulism.
November 2011, Clinical and vaccine immunology : CVI,
M G Koenig, and D E Rogers
Foodborne botulism treated with heptavalent botulism antitoxin.
February 2013, The Annals of pharmacotherapy,
M G Koenig, and D E Rogers
[Antitoxin accident during botulism].
January 1992, Annales francaises d'anesthesie et de reanimation,
M G Koenig, and D E Rogers
Release of botulism antitoxin.
August 1986, MMWR. Morbidity and mortality weekly report,
M G Koenig, and D E Rogers
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.
January 2019, PloS one,
M G Koenig, and D E Rogers
Infant botulism in Australia: availability of human botulinum antitoxin for treatment.
November 2010, The Medical journal of Australia,
M G Koenig, and D E Rogers
In brief: heptavalent botulism antitoxin.
May 2014, The Medical letter on drugs and therapeutics,
M G Koenig, and D E Rogers
Early antitoxin treatment in wound botulism results in better outcome.
January 2003, European neurology,
Copied contents to your clipboard!